This NDC is on FDA's drug shortage list (posted Jul 26, 2023)

Product Information

METHYLPHENIDATE ER 54 MG TAB is a generic product labeled by Actavis Pharma, Inc., priced at $0.8220 per EA under NDC 62037072701. Its NADAC has been published 388 times since Jun 12, 2019.

FDA first approved this application on Mar 21, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPHENIDATE ER 54 MG TAB

Methylphenidate Hydrochloride
$0.8220per EA
DEA Schedule CII

Strength

54 mg/1

NDC

62037072701

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA076655

FDA Approved

3/21/2018

TE Code

AB

On Market Since

3/4/2019

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE ER 54 MG TAB has been published 388 times since Jun 12, 2019, and over the history we have for it it has declined 88.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.8220 per EA
All-time high$7.0978 (Jun 12, 2019)
All-time low$0.6051 (Feb 22, 2023)
52-week high$0.8447
52-week low$0.7632
Median price$0.8980
Average price$1.6485
Largest weekly change+71.1% (Nov 22, 2023)
Weeks tracked388
Tracking sinceJun 12, 2019

Price History

1W

0.0%

1M

+2.1%

3M

+1.4%

6M

+1.7%

1Y

-0.9%

3Y

+11.0%

5Y

-37.5%

All

-88.4%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE ER 54 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 54 MG TAB, manufactured by Actavis Pharma, Inc., is $0.8220 per EA (NDC 62037072701), effective Nov 11, 2026.

How has the price of METHYLPHENIDATE ER 54 MG TAB changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE ER 54 MG TAB has declined 88.4%. It has been tracked across 388 weekly CMS publications since Jun 12, 2019.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 54 MG TAB?

Since Jun 12, 2019, the NADAC for METHYLPHENIDATE ER 54 MG TAB has ranged from a low of $0.6051 (Feb 22, 2023) to a high of $7.0978 (Jun 12, 2019), with a median of $0.8980 per EA.

Are there cheaper alternatives to METHYLPHENIDATE ER 54 MG TAB?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE ER 54 MG TAB, is $0.8092 per EA — about 2% below METHYLPHENIDATE ER 54 MG TAB.

Who manufactures METHYLPHENIDATE ER 54 MG TAB?

METHYLPHENIDATE ER 54 MG TAB (NDC 62037072701) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.

Is METHYLPHENIDATE ER 54 MG TAB in shortage?

Yes — NDC 62037072701 is currently listed in FDA's drug shortage database (posted Jul 26, 2023).